Sunshine Biopharma, Inc | Business Contracts

Form of Pre-Funded Warrant (Filed With SEC on May 16, 2023)

Form of Registration Rights Agreement (Filed With SEC on May 16, 2023)

Form of Warrant (Filed With SEC on May 16, 2023)

Form of Securities Purchase Agreement (Filed With SEC on May 16, 2023)

Placement Agent Agreement dated May 12, 2023 (Filed With SEC on May 16, 2023)

The License Agreement between the Company and the University of Arizona (Filed With SEC on February 28, 2023)

Research Agreement between the Company and JGH (Filed With SEC on February 10, 2023)

Employment Agreement between Sunshine Biopharma, Inc., Nora Pharma Inc. and Malek Chamoun (Filed With SEC on October 20, 2022)

Share Purchase Agreement between Sunshine Biopharma, Inc., Malek Chamoun and Nora Pharma Inc (Filed With SEC on October 20, 2022)

Form of Warrant (Filed With SEC on April 28, 2022)

Form of Pre-Funded Warrant (Filed With SEC on April 28, 2022)

Form of Registration Rights Agreement (Filed With SEC on April 28, 2022)

Form of Securities Purchase Agreement (Filed With SEC on April 28, 2022)

Engagement Letter dated April 25, 2022 (Filed With SEC on April 28, 2022)

Employment Agreement between Sunshine Biopharma, Inc. and Dr. Steve Slilaty (Filed With SEC on April 8, 2022)

Description of Registrants Securities (Filed With SEC on March 21, 2022)

Form of Warrant (Filed With SEC on March 15, 2022)

Form of Registration Rights Agreement (Filed With SEC on March 15, 2022)

Form of Pre-Funded Warrant (Filed With SEC on March 15, 2022)

Engagement Letter dated March 9, 2022, as amended (Filed With SEC on March 15, 2022)

Form of Securities Purchase Agreement (Filed With SEC on March 15, 2022)

Research Agreement, dated February 18, 2022, between the Company and the University (Filed With SEC on February 25, 2022)

Warrant Agency Agreement between Sunshine Biopharma, Inc. and Equiniti Trust Company, dated February 17, 2022 (Filed With SEC on February 17, 2022)

Underwriting Agreement between Sunshine Biopharma, Inc. and Aegis Capital Corp., dated February 15, 2022 (Filed With SEC on February 17, 2022)

Form of Warrant (Filed With SEC on February 17, 2022)

Form of Warrant for offering (Filed With SEC on February 14, 2022)

Form of Underwriting Agreement (Filed With SEC on February 14, 2022)

Form of Warrant Agent Agreement (Filed With SEC on February 9, 2022)

Form of Underwriting Agreement (Filed With SEC on February 9, 2022)

Form of Warrant for offering (Filed With SEC on February 9, 2022)

Form of Pre-Funded Warrant for offering (Filed With SEC on February 9, 2022)

Sponsored Research Agreement, dated October 6, 2020, between the Company and the University of Georgia Research Foundation, Inc (Filed With SEC on January 24, 2022)

Financing Agreement with RB Capital Partners, Inc (Filed With SEC on September 15, 2020)

Share Transfer Agreement with Atlas Pharma Inc., et al (Filed With SEC on July 19, 2019)

Registration Rights Agreement dated September 10, 2018 by and between Sunshine Biopharma, Inc. and GHS Investments, LLC (Filed With SEC on September 14, 2018)

Equity Financing Agreement dated September 10, 2018 by and between Sunshine Biopharma, Inc. and GHS Investments, LLC (Filed With SEC on September 14, 2018)

Promissory Note issued by Sunshine Biopharma, Inc. in favor of GHS Investments LLC (Filed With SEC on September 14, 2018)

AMENDMENT NO. 1 TO PATENT PURCHASE AGREEMENT By and Between SUNSHINE BIOPHARMA, INC. And ADVANOMICS CORPORATION Dated as of March 14, 2016 (Filed With SEC on March 14, 2016)

Patent Purchase Agreement with Advanomics Corporation (Filed With SEC on December 28, 2015)

PATENT PURCHASE AGREEMENT By and Between SUNSHINE BIOPHARMA, INC. And ADVANOMICS CORPORATION Dated as of October 8, 2015 PATENT PURCHASE AGREEMENT (Filed With SEC on October 9, 2015)

INVESTMENT AGREEMENT (Filed With SEC on April 28, 2014)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on April 28, 2014)

AMENDMENT 2 TO EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on December 27, 2011)

Sunshine Biopharma, Inc (44)